Why did BASF's Q2 net profit surge over 50-fold year-on-year, and what key factors drove this exceptional performance?

BASF's Q2 net profit soared from €79 million to €4.1 billion — an increase of over 50 times — primarily driven by a 16% sales growth to €17.2 billion, fueled by 11.5% price increases across most business areas (chemicals, surface technologies, materials, and industrial solutions) and a 7.3% volume gain. Its EBITDA before special items reached €2.4 billion — significantly above the €2.1 billion analyst consensus — reflecting strong pricing power and operational resilience despite high energy costs and geopolitical disruptions. The company attributed this outperformance to successful cost-cutting, business restructuring, and sustained demand in consumer-facing segments.

What do the upward revisions to full-year EBITDA guidance by BASF, Evonik, Wacker Chemie, and Sika collectively indicate about the European chemical industry’s current trajectory?

The simultaneous upward revisions to full-year EBITDA guidance by BASF (to €6.9–7.7 billion), Evonik (to €2.0–2.2 billion), Wacker Chemie (to €625–750 million), and Sika (to 'at least €1.1 billion') signal a short-term earnings rebound rooted in pricing discipline, portfolio optimization, and selective demand strength — especially in AI-driven semiconductor silicones, specialty additives, nutrition & consumer chemicals, and high-growth composites. However, this optimism is tempered and not indicative of broad-based demand recovery, as evidenced by ongoing EU-wide production declines (−3.2% YoY in Q1 2026), persistently low capacity utilization (74.3% vs. 81.3% long-term average), and cautious outlooks citing geopolitical uncertainty, elevated carbon prices (>€80/ton), and structural demand weakness — confirming that the Q2 outperformance reflects tactical profit repair rather than sustainable cyclical upturn.

European Chemical Giants' Q2 Performance Generally Exceeds Expectations

Aug 4, 2026

Major European chemical firms including BASF and Evonik reported Q2 earnings beating expectations driven by price increases, prompting raised full-year forecasts despite persistent industry production challenges.

ccin

2026-05-08

Evonik Expects Q2 Tailwinds from Customer Stockpiling Amid Middle East War Impact

2026-08-04

European Chemical Giants' Q2 Performance Generally Exceeds Expectations

European Chemical Giants' Q2 Performance Generally Exceeds Expectations

FAQ